AskBio Highlights Six Presentations at ASGCT 29th Annual Meeting
AskBio to Present New Gene Therapy and AAV Manufacturing Research at ASGCT 2026 AskBio, a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has…
Read MoreAskBio Highlights Six Presentations at ASGCT 29th Annual Meeting
Hartford HealthCare Adds MinuteClinic as In-Network Primary Care Option Across Clinically Integrated Network
MinuteClinic and Hartford HealthCare Expand Collaboration to Offer In-Network Adult Primary Care Across Connecticut MinuteClinic, the retail medical clinic network located within select CVS Pharmacy stores, and Hartford HealthCare, one…
Johnson & Johnson Launches Generation Fine Campaign Focused on Depression Remission
Johnson & Johnson Launches “Generation Fine” Campaign to Encourage Better Conversations Around Depression Care and Remission Johnson & Johnson has launched Generation Fine, a new global awareness campaign focused on…
MOVIVA Launch Takes Center Stage at ESGE Days 2026
Erbe Highlights New MOVIVA® Endoscopic Obesity Therapy Platform During 175th Anniversary Year Erbe Elektromedizin GmbH is marking its 175th anniversary by showcasing continued innovation in minimally invasive healthcare technologies with…
Altasciences and Certara Form Strategic Partnership to Advance Early-Stage Drug Development
Altasciences and Certara Form Strategic Partnership to Advance Model-Informed Drug Development Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development through the integration of model-informed…
Rapid Medical’s TIGERTRIEVER 13 Shows Encouraging 90-Day Results in DISTALS Trial, Supporting Key Safety and Efficacy Data
Rapid Medical Reports Positive DISTALS Trial Results for TIGERTRIEVER 13 in Distal Stroke Treatment Rapid Medical, a medical technology company focused on advanced stroke treatment solutions, has announced full results…
Rocket Pharmaceuticals Announces First Quarter 2026 Financial Results and Recent Business Highlights
Rocket Pharmaceuticals Reports First Quarter 2026 Results and Advances Cardiovascular Gene Therapy Pipeline Rocket Pharmaceuticals, a commercial-stage biotechnology company focused on developing genetic therapies for rare and life-threatening disorders, has…
Aptar Pharma Reports Advancements in Multi-Year U.S. FDA-Funded Research Program
Aptar Pharma Advances FDA-Supported Research on Next-Generation Propellants for Metered-Dose Inhalers Aptar Pharma, a global company specializing in drug delivery systems, dosing technologies, protection solutions, and pharmaceutical services, has announced…
Reprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure
Reprieve Cardiovascular Reports Published FASTR Pilot Study Results Supporting Potential New Approach for Acute Heart Failure Treatment Reprieve Cardiovascular, a development-stage medical technology company focused on transforming the treatment of…
Seek Labs Secures U.S. Patent for Novel Isothermal Molecular Amplification Technology Supporting Decentralized Diagnostic Testing
Seek Labs Secures U.S. Patent for Innovative Isothermal Amplification Technology Designed to Advance Decentralized Molecular Diagnostics Seek Labs, a private TechBio company focused on building programmable platforms to decode, program,…
Viridian Therapeutics Plans Concurrent Offerings of Notes, Common Stock, and Preferred Shares
Viridian Therapeutics Plans Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Shares, and Series B Non-Voting Convertible Preferred Stock Viridian Therapeutics (Nasdaq: VRDN), a clinical-stage biopharmaceutical company focused…
Travere Therapeutics Unveils Convertible Senior Notes Offering to Refinance 2029 Debt
Travere Therapeutics Unveils Planned Convertible Senior Notes Offering to Refinance Existing 2029 Notes Travere Therapeutics (Nasdaq: TVTX) has announced plans to initiate an underwritten public offering of $400 million in…